News

2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...
The Week30m

COVID-19 vaccine causing eye issues? Research puts Pfizer jab in spotlight

While no vision loss was noted, researchers observed slight corneal thickening and decreased endothelial cell count, prompting calls for close monitoring in vulnerable individuals.

Here's Why Vanguard's Worst-Performing Sector ETF Is a No-Brainer Buy Right Now

Key Points The largest healthcare stocks by market capitalization are undergoing significant sell-offs.This low-cost ETF ...
The Manila Times4h

Ocugen, Inc. Announces New Appointments to Retina Scientific Advisory Board & Executive Leadership Team

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness ...
TheHealthSite7h

Pfizer-BioNTech's COVID-19 Vaccine: What Does A Thicker Cornea And Reduced Cell Density Mean?

BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...

Pfizer COVID jab 'linked to major eye damage and sight loss' as scientists make shock find

Scientists in Turkey found that the Pfizer COVID-19 vaccine impacted some people's corneas, according to a study.